We have invested more than $446 million into finding the causes, treatments, and cures for Crohn’s disease and ulcerative colitis. And we won’t stop until we realize our vision of a future free from Crohn’s and colitis.

Our goal this year is to raise over $300,000 for our mission while we recognize our Honoree, Robby Edelstein and our Impact Speaker, Dara Klugherz